Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Argus Health
Queensland Health
Farmers Insurance
Boehringer Ingelheim

Generated: March 20, 2019

DrugPatentWatch Database Preview

Mefloquine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mefloquine hydrochloride and what is the scope of mefloquine hydrochloride freedom to operate?

Mefloquine hydrochloride is the generic ingredient in two branded drugs marketed by Roche, Barr, Hikma Intl Pharms, Sandoz, Us Army Walter Reed, and West-ward Pharms Int, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for mefloquine hydrochloride. Seven suppliers are listed for this compound.

Pharmacology for mefloquine hydrochloride
Drug ClassAntimalarial
Medical Subject Heading (MeSH) Categories for mefloquine hydrochloride
Synonyms for mefloquine hydrochloride
(+/-)-Mefloquine Hydrochloride
(|AS)-rel-|A-(2R)-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
(AS)-rel-a-(2R)-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride
(AS)?-?rel-?a-?(2R)?-?2-?Piperidinyl-?2,8-?bis(trifluoromethyl)?-?4-?quinolinemethanol monohydrochloride
(R)-(2,8-bis(trifluoromethyl)quinolin-4-yl)((S)-piperidin-2-yl)methanol hydrochloride
(R)-[2,8-bis(trifluoromethyl)-4-quinolinyl][(2S)-2-piperidinyl]methanol hydrochloride
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol;hydrochloride
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2S)-piperidin-2-yl]methanol hydrochloride
(R*,S*)-(1)-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol monohydrochloride
(R*,S*)-(2,8-Bis-trifluoromethyl-quinolin-4-yl)-piperidin-2-yl-methanol hydrochloride
(S)-(2,8-bis(trifluoromethyl)quinolin-4-yl)((R)-piperidin-2-yl)methanolhydrochloride
(S)-[2,8-bis(trifluoromethyl)-4-quinolyl]-[(2R)-2-piperidyl]methanol hydrochloride
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol hydrochloride
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol hydrochloride
[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol hydrochloride
326VC85GV6
4-Quinolinemethanol, 2,8-bis(trifluoromethyl)-alpha-2-piperidinyl-, monohydrochloride,(R*,S*)-, (+-)-
4-Quinolinemethanol, alpha-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-, monohydrochloride, (alphaS)-rel-
4-Quinolinemethanol, alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, monohydrochloride, (R*,S*)- (+-)-
4-Quinolinemethanol, alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, monohydrochloride, (R*,S*)-(+-)-
4-Quinolinemethanol,alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-,(R*,S*)-(+-)
51742-86-0
51744-83-3
51773-92-3
68682-28-0
773M923
AB0015316
AB07167
AB1008604
AC-4686
AC1L232A
AC1L9B1J
AK-78309
AKOS015919767
AKOS025212860
AN-11705
API0005844
AX8016625
B-1797
BC202800
BCP01049
BR-78309
C-21982
C17H16F6N2O.HCl
CAS-51773-92-3
CCG-213099
CHEBI:6719
CHEMBL1606
CHEMBL535650
CPD000875233
CS-1430
CTK9A0932
D00831
DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride
DSSTox_CID_27796
DSSTox_GSID_47819
DSSTox_RID_82568
DTXSID1047819
EINECS 257-412-0
GNF-Pf-5559
GS-3621
HMS1568I14
HY-17437A
KS-000015FZ
Lariam (TN)
Loriam
LS-142001
M2313
M637
MCULE-2230999659
Mefloquin Hydrochloride
Mefloquine (hydrochloride)
Mefloquine HCL
Mefloquine hydrochloride (JP17/USP)
Mefloquine hydrochloride [USAN:USP]
Mefloquine hydrochloride [USAN]
Mefloquine hydrochloride, (+)
Mefloquine hydrochloride, >=98% (HPLC), powder
Mefloquine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Mefloquine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Mefloquine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Mefloquinehydrochloride
Mephaquin
MFCD00797519
MLS001332559
MLS001332560
MLS002154206
MLS006011973
MolPort-005-933-138
MolPort-023-278-202
NC00622
NCGC00161831-02
NCGC00161831-04
NSC 157387
NSC-157387
NSC-758233
NSC157387
NSC758233
PC404546
Pharmakon1600-01503070
Prestwick_538
Q-201345
Ro 21-5998/001
Ro-21-5998/001
Ro-215998001
s4420
SAM002699894
SC-72482
SCHEMBL41094
SCHEMBL41095
SCHEMBL5040024
SMR000875233
SMR001233492
SMR004703536
SR-05000001820
SR-05000001820-4
SW220098-1
TCMDC-123920
TCMDC-124288
Tox21_111999
Tox21_111999_1
UNII-326VC85GV6
UNII-5Y9L3636O3 component WESWYMRNZNDGBX-SBKWZQTDSA-N
UNII-5Y9L3636O3 component WESWYMRNZNDGBX-YLCXCWDSSA-N
WR 142,490
WR 142490 hydrochloride
Z1563146097

US Patents and Regulatory Information for mefloquine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 076392-001 Dec 29, 2003 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roche LARIAM mefloquine hydrochloride TABLET;ORAL 019591-001 May 2, 1989 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Us Army Walter Reed MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 019578-001 May 2, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 076175-001 Feb 20, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Intl Pharms MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 077699-001 Apr 21, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 076523-001 Oct 1, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Express Scripts
Deloitte
Citi
Mallinckrodt
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.